Timoptol

Timoptol Dosage/Direction for Use

timolol

Manufacturer:

Santen

Distributor:

Metro Drug
Full Prescribing Info
Dosage/Direction for Use
The usual starting dose is one drop of 0.25 percent timolol maleate ophthalmic solution in the affected eye(s) as directed. If the clinical response is not adequate, the dosage may be changed to one drop of 0.5 percent solution in the affected eye(s) twice a day.
If needed, concomitant therapy with other agent(s) for lowering intraocular pressure may be given with TIMOLOL MALEATE (TIMOPTOL). The use of two topical beta-adrenergic blocking agents is not recommended (see WARNINGS AND PRECAUTIONS).
Since in some patients the pressure-lowering response to TIMOLOL MALEATE (TIMOPTOL) may require a few weeks to stabilize, evaluation should include a determination of intraocular pressure after approximately 4 weeks of treatment with TIMOLOL MALEATE (TIMOPTOL).
If the intraocular pressure is maintained at satisfactory levels, many patients can be placed on once-a-day therapy.
When using nasolacrimal occlusion or closing the eyelids for 2 minutes, the systemic absorption is reduced. This may result in an increase in local activity.
HOW TO TRANSFER PATIENTS FROM OTHER THERAPY: When a patient is transferred from another topical ophthalmic β-adrenergic blocking agent, that agent should be discontinued after proper dosing on one day and treatment with TIMOLOL MALEATE (TIMOPTOL) started on the following day with one drop of 0.25 percent timolol maleate ophthalmic solution in the affected eye(s) as directed. The dose may be increased to one drop of 0.5 percent TIMOLOL MALEATE (TIMOPTOL) in the affected eye twice a day if the clinical response is not adequate.
When a patient is transferred from a single antiglaucoma agent, other than a topical ophthalmic beta‑adrenergic blocking agent, continue the agent already being used and add one drop of 0.25 percent timolol maleate ophthalmic solution in the affected eye(s) as directed. On the following day, discontinue the previously used antiglaucoma agent completely and continue with the TIMOLOL MALEATE (TIMOPTOL) ophthalmic solution. If a higher dosage is required substitute one drop of 0.5 percent TIMOLOL MALEATE (TIMOPTOL) in each affected eye twice a day.
Use in children: The usual starting dosage is one drop 0.25 percent TIMOLOL MALEATE (TIMOPTOL) in the affected eye(s) every 12 hours, in addition to other antiglaucoma medication. The dosage may be increased to one drop of 0.5 percent solution in the affected eye(s) every 12 hours, if necessary. The use of TIMOLOL MALEATE (TIMOPTOL) is not recommended in premature infants or neonates.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in